ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Video Support Program For Families With a Parent Newly Diagnosed With Cancer

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: Inflexxion
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00020553
  Purpose

RATIONALE: A videotape support program may help families improve communication and coping skills when a parent is diagnosed with cancer.

PURPOSE: Randomized trial to study the effectiveness of a video support program for families who have a parent who has been newly diagnosed with cancer.


Condition Intervention
Cancer-Related Problem/Condition
Procedure: psychosocial assessment and care

MedlinePlus related topics:   Cancer   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Other
Official Title:   We Can Cope: Family Support When A Parent Has Cancer

Further study details as provided by National Cancer Institute (NCI):

Study Start Date:   August 2000

Detailed Description:

OBJECTIVES: I. Determine if families who participate in a video support program function better as a family in the areas of communication, togetherness, and overall increased ability to cope when a parent is newly diagnosed with cancer. II. Determine if participation in this program decreases stress-related illness in the well members of the family. III. Determine the safety of this program. IV. Determine patient/family and medical provider satisfaction with this program.

OUTLINE: This a randomized study. Adult parent participants and spouses undergo a baseline assessment over approximately 1 hour comprising completion of a self-assessment form followed by an interview. Families are then randomized to one of two arms. Arm I: Adult parent participants receive a video support program comprising 3 videotapes (parent tape, adolescent tape, and child tape) and a parent guidebook. The parents are encouraged to screen the videotapes and decide whether to have their child and/or adolescent view the program. Arm II: Adult parent participants receive no video support material. Families may view the video program after study completion. Adult parent participants in both arms complete follow-up assessments at 6 and 12 weeks. This clinical trial is being conducted at the locations listed below. If you are interested in this clinical trial but unable to visit these locations, please call #1-800-848-3895 ext. 226 and ask for more information about the We Can Cope study.

PROJECTED ACCRUAL: A total of 230 families will be accrued for this study.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

DISEASE CHARACTERISTICS: Parent with a first diagnosis of cancer within the past 5 years No recurrence of a previously diagnosed cancer Must have at least 1 child between the ages of 6 and 18 Ill parent must live with child/children at least 50% of the time No plans to move out-of-state within the next 3 months

PATIENT CHARACTERISTICS: Age: See Disease Characteristics Any age Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: No psychotic disorder (such as schizophrenia) or a brain/psychiatric disorder due to disease/illness

PRIOR CONCURRENT THERAPY: Not specified

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00020553

Locations
United States, Maine
Maine Center for Cancer Medicine and Blood Disorders    
      Scarborough, Maine, United States, 04074
United States, Massachusetts
Inflexxion    
      Newton, Massachusetts, United States, 02464-1594
United States, New York
Albert Einstein Comprehensive Cancer Center    
      Bronx, New York, United States, 10461
United States, North Carolina
Buddy Kemp Caring House    
      Charlotte, North Carolina, United States, 28207
United States, Texas
Baylor University Medical Center    
      Dallas, Texas, United States, 75246

Sponsors and Collaborators

Investigators
Study Chair:     Jonas I. Bromberg     Inflexxion    
  More Information


Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   CDR0000068602, INFLEXXION-000080, ITS-000080, NCI-V01-1659
First Received:   July 11, 2001
Last Updated:   October 18, 2008
ClinicalTrials.gov Identifier:   NCT00020553
Health Authority:   United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
psychosocial effects/treatment  

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers